Colliers Securities Maintains Medical Properties Trust Inc(MPW.US) With Hold Rating, Maintains Target Price $5
Maintaining Hold on Medical Properties Trust Amid Steward Healthcare Uncertainties and Dividend Cut Concerns
Medical Properties Trust Analyst Ratings
BNP Paribas Exane Downgrades Medical Properties Trust to Neutral From Outperform, Adjusts Price Target to $4 From $6
Medical Properties Trust Analyst Ratings
Truist Adjusts Price Target on Medical Properties Trust to $5 From $4.50, Maintains Hold Rating
Medical Properties Trust Analyst Ratings
Maintaining Hold on Medical Properties Trust Amid Asset Sales and Debt Management Efforts
Medical Properties Trust Analyst Ratings
Balancing Liquidity Gains and Ongoing Risks: Hold Rating on Medical Properties Trust
Medical Properties Trust Sell Rating: Liquidity Boost Vs. Portfolio Quality Concerns
M&A News: Medical Properties (NYSE:MPW) Surges After Selling $1B in Assets
Medical Properties Trust Analyst Ratings
Medical Properties Trust Analyst Ratings
What 4 Analyst Ratings Have To Say About Medical Properties Trust
Medical Properties Trust Analyst Ratings
Medical Properties Trust Analyst Ratings
Medical Properties Trust Analyst Ratings
Mizuho Maintains Neutral on Medical Properties Trust, Lowers Price Target to $7
Medical Properties Trust Analyst Ratings